Evaluating genome editing tools in nonhuman primates
Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools
This study is exploring new ways to edit genes in nonhuman primates to help develop better treatments for human diseases, and it could lead to exciting new therapies for patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10599914 on NIH RePORTER |
What this research studies
This research focuses on advancing the field of genome editing by conducting studies in nonhuman primates, specifically targeting the development and evaluation of somatic cell genome editing tools. The project is based at the University of California, Davis, and involves a collaborative team of experts who will utilize state-of-the-art facilities and resources to conduct high-quality research. By leveraging existing partnerships and infrastructure, the center aims to accelerate the translation of genome editing technologies for potential human disease treatments. Patients may benefit from the insights gained through these studies as they could lead to innovative therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals with genetic disorders that could potentially be treated with genome editing technologies.
Not a fit: Patients with conditions that are not amenable to genome editing or those who do not have genetic components to their diseases may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could pave the way for new treatments for various human diseases through advanced genome editing techniques.
How similar studies have performed: Other research in the field of genome editing has shown promising results, indicating that this approach has the potential for significant advancements in medical treatment.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Tarantal, Alice F — University of California at Davis
- Study coordinator: Tarantal, Alice F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.